BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 6203969)

  • 1. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.
    Golding H; Singer A
    J Immunol; 1984 Aug; 133(2):597-605. PubMed ID: 6203969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.
    Kruisbeek AM; Andrysiak PM; Singer A
    J Immunol; 1983 Oct; 131(4):1650-5. PubMed ID: 6604748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
    J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CTL responses to alloantigens by a Db-specific T helper clone.
    Kwong PC; Kilburn DG; Teh HS
    J Immunol; 1984 Aug; 133(2):653-9. PubMed ID: 6203972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
    Golding H; Singer A
    J Immunol; 1985 Sep; 135(3):1610-5. PubMed ID: 3874902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
    Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
    J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of syngeneic Ia+ accessory cells in the generation of allospecific CTL responses.
    Weinberger O; Germain RN; Springer T; Burakoff SJ
    J Immunol; 1982 Aug; 129(2):694-7. PubMed ID: 6979580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive cytotoxic T lymphocyte responses to H-2 products on purified accessory cells.
    Czitrom AA; Katz DR; Sunshine GH
    Immunology; 1982 Mar; 45(3):553-60. PubMed ID: 6460688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary T-cell responses to minor alloantigens. II. Analysis of accessory cell requirements for the development of cytotoxic T lymphocytes.
    Czitrom AA; Liddell M
    Immunology; 1983 Dec; 50(4):555-63. PubMed ID: 6228514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genes.
    Golding H; Bluestone J; Satz ML; Singer D; Singer A
    J Immunol; 1985 Jun; 134(6):3557-9. PubMed ID: 2580888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.